Atlas Trials

Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B

Clinical trial NCT00076557 · TERMINATED

Trial details

NCT number
NCT00076557
Sponsor
Avigen
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hemophilia B
Start date
2004-01-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.